Alveolar soft tissue sarcoma: a report of 50 cases at a single institution

References

• Enzinger FM, Weiss SW. Malignant tumors of uncertain type. In: Enzinger FM, Weiss SW, editors. Soft tissue tumors. St. Louis: Mosby; 1995. 1067–1074.
   Google Scholar
• Christopherson WM, Foote FW, Stewart FW. Alveolar soft-part sarcomas; structurally characteristic tumors of uncertain histogenesis. Cancer. 1952; 5(1):100–111.
   PubMed Web of Science ®Google Scholar
• Alegría-Landa V, Lora V, Cota C, et al. Alveolar soft-part sarcoma of the tongue. Am J Dermatopathol. 2019;41(3):218–220.
   PubMed Web of Science ®Google Scholar
• Bu X, Bernstein L. A proposed explanation for female predominance in alveolar soft part sarcoma. Noninactivation of X; autosome translocation fusion gene? Cancer. 2005;103(6):1245–1253.
   PubMed Web of Science ®Google Scholar
• Lieberman PH, Brennan MF, Kimmel M, et al. Alveolar soft part sarcoma. A clinico-pathologic study of half a century. Cancer. 1989;63(1):1–13.
   PubMed Web of Science ®Google Scholar
• Portera CA, Jr, Ho V, Patel SR, et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001;91(3):585–591.
   PubMed Web of Science ®Google Scholar
• Ogose A, Yazawa Y, Ueda T, et al. Japanese musculoskeletal oncology group. Alveolar soft part sarcoma in Japan: multi-institutional study of 57 patients from the Japanese musculoskeletal oncology group. Oncology. 2003;65(1):7–13.
   PubMed Web of Science ®Google Scholar
• Kurtz JE, Andrès E, Rohr S, et al. Pancreatic metastasis of alveolar soft-part sarcoma: a case report and review of the literature. Ann Oncol. 2001;12(6):865–867.
   PubMed Web of Science ®Google Scholar
• Shweikeh F, Bukavina L, Saeed K, et al. Brain metastasis in bone and soft tissue cancers: a review of incidence, interventions, and outcomes. Sarcoma. 2014;2014:1–19.
   Google Scholar
• Malouf GG, Beinse G, Adam J, et al. Brain metastases and place of antiangiogenic therapies in alveolar soft part sarcoma: a retrospective analysis of the French sarcoma group. Oncologist. 2019;24(7):980–988.
   PubMed Web of Science ®Google Scholar
• Wang H, Jacobson A, Harmon DC, et al. Prognostic factors in alveolar soft part sarcoma: a SEER analysis. J Surg Oncol. 2016;113(5):581–586.
   PubMed Web of Science ®Google Scholar
• Fletcher CDM, Bridge JA, Hogendoorn PCW, et al. World Health Organization (WHO) classification of tumors of soft tissue and bone. Pathol Genet. Lyon, France: IARC Press; 2013. p. 218–220.
   Google Scholar
• Mark NJ, Muhieddine S, Hikmat AA, et al. ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma. Int J Gynecol Pathol. 2014;33(3):263–267.
   PubMed Web of Science ®Google Scholar
• Asano Y, Kashiwagi S, Takada K, et al. Alveolar soft part sarcoma metastatic to the breast: a case report. BMC Surg. 2019;19(1):30.
   PubMed Web of Science ®Google Scholar
• Reichardt P, Lindner T, Pink D, et al. Chemotherapy in alveolar soft part sarcomas. What do we know? Eur J Cancer. 2003;39(11):1511–1516.
   PubMed Web of Science ®Google Scholar
• Soheilifar MH, Taheri RA, Zolfaghari Emameh R, et al. Molecular landscape in alveolar soft part sarcoma: implications for molecular targeted therapy. Biomed Pharmacother. 2018;103:889–896.
   Google Scholar
• Daigeler A, KuhnenC, Hauser J, et al. Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases. World J Surg Oncol. 2008;6:71.
   Google Scholar
• Lin YK, WuPK, Chen CF, et al. Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 13 patients. J Chin Med Assoc. 2018;81(8):735–741.
   Google Scholar
• Orbach D, BrennanB, Casanova M, et al. Paediatric and adolescent alveolar soft part sarcoma: a joint series from European cooperative groups. Pediatr Blood Cancer. 2013;60(11):1826–1832.
   Google Scholar
• Flores RJ, HarrisonDJ, Federman NC, et al. Alveolar soft part sarcoma in children and young adults: a report of 69 cases. Pediatr Blood Cancer. 2018;65(5):e26953.
   Google Scholar
• Ogura K, BeppuY, Chuman H, et al. Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature. Sarcoma. 2012;2012:907179.
   Google Scholar
• Liu YP, JinJ, Wang WH, et al. A retrospective analysis of lung metastasis in 64 patients with alveolar soft part sarcoma. Clin Transl Oncol. 2015;17(10):803–809.
   Google Scholar
• Kumar A, AlrohmainB, Taylor W, et al. Alveolar soft part sarcoma: the new primary intracranial malignancy: a case report and review of the literature. Neurosurg Rev. 2019;42(1):23–29.
   Google Scholar
• Liu J, FanZ, Li S, et al. Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases. Ann Transl Med. 2020;8(22):1493.
   Google Scholar
• Monga V, SkubitzKM, Maliske S, et al. A retrospective analysis of the efficacy of immunotherapy in metastatic soft-tissue sarcomas. Cancers. 2020;12(7):1873.
   Google Scholar
• Anderson ME, Hornicek FJ, Gebhardt MC, et al. Alveolar soft part sarcoma: a rare and enigmatic entity. Clin Orthop Relat Res. 2005;438:144–148.
   PubMedGoogle Scholar
• Cormier JN, PatelSR, Herzog CE, et al. Concurrent ifosfamide-based chemotherapy and irradiation. analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001;92(6):1550–1555.
   Google Scholar
• Read WL, Williams F. Metastatic alveolar soft part sarcoma responsive to pazopanib after progression through sunitinib and bevacizumab: two cases. Case Rep Oncol. 2016;9(3):639–643.
   Google Scholar
• Judson I, MordenJP, Kilburn L, et al. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial. Lancet Oncol. 2019;20(7):1023–1034.
   Google Scholar
• Brahmi M, VanackerH, Dufresne A. Novel therapeutic options for alveolar soft part sarcoma: antiangiogenic therapy, immunotherapy and beyond. Curr Opin Oncol. 2020;32(4):295–300.
   Google Scholar